Fatima Carrico is a seasoned pharmaceutical professional and clinical supply chain leader with a proven track record of driving results through strategic planning, meticulous project management, and cross-functional collaboration. With a strong focus on detail and a commitment to quality, she has developed innovative solutions while demonstrating exceptional competence in strategic risk management. Her agility in navigating the regulatory landscape is complemented by a deep dedication to building strong partnerships and achieving organizational goals, ultimately serving the needs of patients.
At Novartis, Fatima currently holds the position of Associate Director, Clinical Supplies Management – Innovative Medicines US, based in East Hanover, New Jersey, United States. In this role, she focuses on efficient strategic planning and project management of drug supply, ensuring the highest standards of quality and regulatory compliance.
Prior to her current role, Fatima served as a Senior CGT Supply Chain Manager for the Global TRD Cell & Gene Therapy Unit and held positions as Lead Trial Manager (LTM) in the Global DSM Oncology Franchise and Sr. DSM Trial Manager for US Oncology.
Throughout her career, she has worked with global clinical trials, including in the fields of US Oncology, Cell & Gene Therapy, and US Pharma. Fatima's experience extends to mentoring and facilitating programs, exemplifying her commitment to personal and professional development.
Before her tenure at Novartis, she worked with renowned pharmaceutical companies such as Merck, Celgene, and Schering Plough, holding various positions that contributed to her well-rounded expertise in clinical supply chain management.
In addition to her professional roles, Fatima is a dedicated advocate for diversity and inclusion (D&I) culture, emphasizing its importance in the workplace.
Fatima Carrico's career is characterized by her ability to drive results and innovation while maintaining a strong focus on quality, regulatory compliance, and strategic risk management. Her passion for serving patients and her commitment to personal and professional development make her a respected leader in the pharmaceutical industry.